BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 7066916)

  • 1. Analysis of the effects of promoting agents on liver and urinary bladder carcinogenesis in rats.
    Ito N; Tatematsu M; Nakanishi K; Tsuda H
    Carcinog Compr Surv; 1982; 7():133-7. PubMed ID: 7066916
    [No Abstract]   [Full Text] [Related]  

  • 2. Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats.
    Nakanishi K; Fukushima S; Hagiwara A; Tamano S; Ito N
    J Natl Cancer Inst; 1982 Mar; 68(3):497-500. PubMed ID: 6950178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance by saccharin of membrane alterations of rat bladder cells induced by subcarcinogenic treatment with bladder carcinogens.
    Kakizoe T; Komatsu H; Niijima T; Kawachi T; Sugimura T
    Cancer Res; 1981 Nov; 41(11 Pt 1):4702-5. PubMed ID: 7306987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion in bladder cancer.
    Hicks RM
    Carcinog Compr Surv; 1982; 7():139-53. PubMed ID: 7039826
    [No Abstract]   [Full Text] [Related]  

  • 5. Organ-specific promoting effect of phenobarbital and saccharin in induction of thyroid, liver, and urinary bladder tumors in rats after initiation with N-nitrosomethylurea.
    Tsuda H; Fukushima S; Imaida K; Kurata Y; Ito N
    Cancer Res; 1983 Jul; 43(7):3292-6. PubMed ID: 6850638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
    Ito N; Fukushima S; Shirai T; Nakanishi K
    Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary bladder carcinogenesis.
    Cohen SM; Hasegawa R; Greenfield RE; Ellwein LB
    IARC Sci Publ; 1984; (56):93-108. PubMed ID: 6536613
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of rat urine fractionated by molecular weight on urinary bladder carcinogenesis.
    Babaya K; Miyata Y; Chmiel JS; Oyasu R
    Cancer Res; 1982 Jan; 42(1):15-8. PubMed ID: 7053843
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Cohen SM; Murasaki G; Fukushima S; Greenfield RE
    Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and assessment of tumor-promoting and cocarcinogenic agents: state-of-the-art in vitro methods.
    Bohrman JS
    Crit Rev Toxicol; 1983; 11(2):121-67. PubMed ID: 6340968
    [No Abstract]   [Full Text] [Related]  

  • 12. Distinction by concanavalin A agglutination between ulceration and repair of rat bladder epithelium induced by freezing or cyclophosphamide and the effect of sodium saccharin.
    Suzuki T; Hasegawa R; Murasaki G; Cohen SM
    Cancer Res; 1984 Jan; 44(1):74-7. PubMed ID: 6690063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of results of agglutination assays with concanavalin A and carcinogenesis experiments on promoters of bladder cancer.
    Kakizoe T; Nishio Y; Ohtani M; Niijima T; Sato S; Sugimura T
    Jpn J Cancer Res; 1985 Oct; 76(10):930-6. PubMed ID: 3935624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific modifying effects of phenobarbital, saccharin and antioxidants on 2-stage chemical carcinogenesis.
    Ito N
    Dev Toxicol Environ Sci; 1986; 12():359-69. PubMed ID: 3549237
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of species, strain, and dose effects in arylamine carcinogenesis.
    Weisburger JH; Fiala ES
    Natl Cancer Inst Monogr; 1981 Dec; (58):41-8. PubMed ID: 7200572
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of N-Methyl-N-Nitrosourea initiated bladder carcinogenesis in Wistar rats by terephthalic acid.
    Cui L; Shi Y; Dai G; Pan H; Chen J; Song L; Wang S; Chang HC; Sheng H; Wang X
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):24-31. PubMed ID: 16045953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of incomplete carcinogens and promoters in hepatocarcinogenesis.
    Pitot HC; Goldsworthy T; Moran S; Sirica AE; Weeks J
    Carcinog Compr Surv; 1982; 7():85-98. PubMed ID: 6802499
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of L-tryptophan and sodium saccharin on urinary tract carcinogenesis initiated by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Fukushima S; Friedell GH; Jacobs JB; Cohen SM
    Cancer Res; 1981 Aug; 41(8):3100-3. PubMed ID: 7248968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental models of 2-stage carcinogenesis].
    Turusov VS
    Eksp Onkol; 1985; 7(3):5-12. PubMed ID: 3893973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.